- Home
- FRST vs DMAC Comparison
FRST vs DMAC Comparison
Compare FRST & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRST
- DMAC
- Stock Information
- Founded
- FRST 2004
- DMAC 2000
- Country
- FRST United States
- DMAC United States
- Employees
- FRST N/A
- DMAC N/A
- Industry
- FRST Major Banks
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- FRST Finance
- DMAC Health Care
- Exchange
- FRST Nasdaq
- DMAC Nasdaq
- Market Cap
- FRST 290.5M
- DMAC 267.7M
- IPO Year
- FRST 2006
- DMAC N/A
- Fundamental
- Price
- FRST $9.93
- DMAC $4.98
- Analyst Decision
- FRST Buy
- DMAC Strong Buy
- Analyst Count
- FRST 1
- DMAC 3
- Target Price
- FRST $14.00
- DMAC $8.00
- AVG Volume (30 Days)
- FRST 108.6K
- DMAC 74.9K
- Earning Date
- FRST 04-24-2025
- DMAC 03-17-2025
- Dividend Yield
- FRST 3.89%
- DMAC N/A
- EPS Growth
- FRST N/A
- DMAC N/A
- EPS
- FRST N/A
- DMAC N/A
- Revenue
- FRST $107,704,000.00
- DMAC N/A
- Revenue This Year
- FRST $40.41
- DMAC N/A
- Revenue Next Year
- FRST $12.70
- DMAC N/A
- P/E Ratio
- FRST N/A
- DMAC N/A
- Revenue Growth
- FRST N/A
- DMAC N/A
- 52 Week Low
- FRST $9.52
- DMAC $2.14
- 52 Week High
- FRST $13.52
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- FRST 39.68
- DMAC 34.11
- Support Level
- FRST $10.01
- DMAC $5.49
- Resistance Level
- FRST $10.30
- DMAC $5.47
- Average True Range (ATR)
- FRST 0.36
- DMAC 0.35
- MACD
- FRST 0.04
- DMAC -0.11
- Stochastic Oscillator
- FRST 39.86
- DMAC 6.32
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.